Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease.
about
Development of WHO guidelines on generalized cost-effectiveness analysis.Statins: balancing benefits, efficacy and safety.Cost effectiveness of statins in coronary heart disease.The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin.Pharmacological basis of different targets for the treatment of atherosclerosis.Cost-effectiveness of HMG-CoA reductase inhibitors in the treatment of dyslipidemia and prevention of CHD.Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus.Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong.Linköping University Medical Dissertation No. 1033. Following the mevalonate pathway to bone heal alley.Optimization of process parameters for supercritical fluid extraction of cholesterol from whole milk powder using ethanol as co-solvent.Secondary prevention fallacy: pitfalls in comparing with primary
P2860
Q33903387-A481B264-3AFC-450A-A2E0-583375F06131Q34628565-E06E1E2D-7FDC-44E1-8A33-8D6E87BD7B4BQ35417723-263623D3-66B2-400E-BA95-BC672E936DDEQ35637978-0FEA1363-510B-4615-B182-92D13F03769EQ36346487-4397C459-50D7-435D-ABCF-6B0448DD6F92Q43266394-7A92B684-A290-40FA-8FF7-E455A56047A4Q44687349-179118C7-6C03-400D-A767-FDBB729A7B35Q44897904-0CF77755-8692-472B-8AA0-8369AC5D0182Q46746321-4A9B7D61-E5D6-4DB8-A5DA-7B6508CCBAB0Q50279144-61EE024F-BC9E-4246-A384-852B0E02BE79Q57589670-15BCFE76-3204-4D6C-A433-95F842012D0E
P2860
Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacoeconomics of lipid-low ...... on of coronary artery disease.
@ast
Pharmacoeconomics of lipid-low ...... on of coronary artery disease.
@en
type
label
Pharmacoeconomics of lipid-low ...... on of coronary artery disease.
@ast
Pharmacoeconomics of lipid-low ...... on of coronary artery disease.
@en
prefLabel
Pharmacoeconomics of lipid-low ...... on of coronary artery disease.
@ast
Pharmacoeconomics of lipid-low ...... on of coronary artery disease.
@en
P2093
P1433
P1476
Pharmacoeconomics of lipid-low ...... on of coronary artery disease.
@en
P2093
P356
10.2165/00019053-199915010-00004
P577
1999-01-01T00:00:00Z
P6179
1022632129